A shareholder agreement may name a valuation formula, a proposed transaction may set a price, and management may have a view of what the business is worth. None of these, by themselves, answers how to value unlisted shares for a purpose that must withstand board, auditor, investor, court or tax scrutiny. The value of shares in a private company depends on the rights attached to those shares, the valuation date, the information available at that date and the specific purpose of the exercise.

Unlike listed securities, unlisted shares do not have a continuously observable market price. A valuation therefore requires considered judgement as well as financial analysis. The objective is not to find a single universally correct number. It is to reach a well-supported conclusion, expressed as a value or range where appropriate, that is fit for purpose and clear about its assumptions.

Start with the valuation purpose and basis of value

The same company can reasonably produce different share values in different circumstances. A value for an employee share plan may be prepared under accounting requirements. A value for a shareholder exit may be governed by a constitution or shareholders’ agreement. A family law, estate, dispute or tax matter may require a particular basis of value and careful treatment of minority interests.

Before selecting a method, establish the valuation date, the relevant standard or legal framework, the intended user and whether the conclusion is required for financial reporting, a transaction, taxation, litigation, employee remuneration or internal planning. This scope determines the evidence required and the assumptions that can properly be made.

It is also necessary to identify the basis of value. Fair value under AASB 13, for example, considers the price that would be received to sell an asset in an orderly transaction between market participants at the measurement date. That is not necessarily the same as strategic value to a particular buyer, nor the amount a shareholder might accept in a forced sale.

How to value unlisted shares: understand what is being sold

A business valuation is not automatically a valuation of every parcel of shares in that business. The shareholding itself may carry rights or restrictions that materially affect value. These can include voting rights, dividend entitlements, conversion features, liquidation preferences, transfer restrictions, drag-along or tag-along provisions, and rights to appoint directors.

The size of the holding matters. A controlling interest may enable the holder to determine dividends, appoint directors or approve a sale. A minority interest may have limited influence over those decisions. Whether a discount for lack of control or a discount for lack of marketability is appropriate depends on the valuation purpose, the basis of value and the facts. Such adjustments should not be applied as a standard percentage simply because shares are unlisted.

A proper review also considers the company constitution, shareholders’ agreement, option or convertible instrument terms, historic transactions and any agreed valuation mechanisms. A formula in an agreement can be decisive if it governs the transaction, but it may not represent fair value for financial reporting or another purpose.

Build the financial and commercial picture

Valuation quality depends on the quality of the underlying information. Financial statements are a starting point, not the final answer. Historical earnings may need adjustment for non-recurring items, owner remuneration, related-party transactions, unusual capital expenditure, one-off grants, discontinued activities or accounting treatments that do not reflect maintainable performance.

Management forecasts warrant particular care. They can be highly relevant, especially for a growth business, but should be tested against past performance, customer concentration, market conditions, funding requirements, planned investment and the assumptions required to deliver the forecast. A forecast is evidence, rather than a fact.

The valuer should also understand the commercial drivers that may not be apparent from the accounts. These might include reliance on key people, contract renewal risk, intellectual property ownership, regulatory approvals, working capital needs, pending litigation, debt covenants and exposure to a small number of customers or suppliers. For early-stage businesses, the pathway to revenue and future financing risk can matter more than current earnings.

Select valuation methods that fit the business

There is no single method that suits every unlisted company. In many assignments, more than one approach is used to test whether the result is commercially coherent.

Income approach

The discounted cash flow method estimates the present value of expected future cash flows. It can be particularly useful where the company has credible forecasts and identifiable long-term earnings drivers. Its strengths are also its sensitivities: the valuation can move significantly with changes to revenue growth, margins, capital expenditure, working capital, terminal value and the discount rate.

The discount rate should reflect the risk of the expected cash flows, including the company’s capital structure and the risks already captured in the forecasts. Double-counting risk, by using highly conservative forecasts and an excessive discount rate, can produce an artificially low outcome.

Market approach

A market approach applies valuation multiples from comparable listed companies or recent transactions, commonly using measures such as earnings before interest, tax, depreciation and amortisation, revenue or earnings. It is often intuitive for boards and transaction parties, but comparability must be assessed rather than assumed.

A listed peer may be larger, more diversified, better funded or more liquid than the subject company. Transaction multiples may include buyer-specific synergies that do not apply to a market participant valuation. Adjustments need a clear rationale, particularly where the market evidence is limited.

Asset-based approach

An asset-based method considers the value of assets less liabilities, with material assets and liabilities measured at appropriate values rather than simply carrying amounts. It may be relevant for investment entities, property-holding companies, asset-rich businesses or companies with limited maintainable earnings.

For an operating business with valuable goodwill, customer relationships or growth prospects, net tangible assets alone may understate value. Conversely, a business generating accounting profits but facing significant unrecognised obligations may require a more cautious assessment.

Recent transaction evidence

A recent arm’s-length sale of shares can be strong evidence, especially where the transaction involves the same class of shares and occurred close to the valuation date. Its relevance reduces where circumstances have changed, the buyer had strategic motives, the sale was between related parties, or the terms included deferred consideration, employment arrangements or other benefits outside the headline price.

Convert enterprise value into equity and share value

Many methods first estimate enterprise value, being the value of the operating business before considering how it is financed. The next step is to reconcile enterprise value to equity value by allowing for debt, surplus cash, investments, leases where relevant, contingent consideration and other non-operating assets or liabilities.

This bridge is a frequent source of error. Cash is not always surplus if it is needed to fund operations. Debt may include shareholder loans or instruments with conversion features. Tax consequences, preference shares and employee options may also affect the value available to ordinary shareholders.

Once equity value is established, the allocation between share classes must follow their economic rights. A simple division by the number of issued shares is only appropriate where all shares rank equally. Where options, convertibles or preference instruments exist, scenario analysis or option-pricing techniques may be required to reflect outcomes across different exit values.

Document assumptions and test sensitivity

A defensible valuation explains not only the conclusion, but how it was reached. The report should identify the information relied upon, valuation date, basis of value, methods considered, key assumptions, limitations and reasons for any discounts or premiums. It should distinguish management representations from independently tested evidence.

Sensitivity analysis is particularly valuable when a conclusion relies on a small number of influential inputs. Showing the effect of reasonable movements in the discount rate, forecast earnings or valuation multiple helps decision-makers understand the range of financial exposure. It also supports more productive discussion at board or audit committee level.

Independence matters where stakeholders have competing interests. A valuation prepared for a shareholder dispute, employee share arrangement or financial reporting purpose should be capable of being explained to parties who did not commission it. Clear analysis does not remove uncertainty, but it makes uncertainty visible and manageable.

When specialist advice is warranted

Specialist valuation support is often appropriate where the share structure is complex, future earnings are uncertain, the value is material to financial statements, or the matter may be reviewed by auditors, regulators or a court. It can also assist when a transaction has not occurred at arm’s length, when shareholder rights differ, or when an employee share-based payment requires an accounting valuation.

An independent actuarial and financial valuation perspective can be particularly useful where there are contingent payments, options, long-term assumptions or multiple scenarios to assess. GM Actuaries works with clients to translate complex modelling and commercial assumptions into conclusions that can support governance and decision-making.

The most useful valuation is one prepared early enough to inform the decision, rather than justify it after the fact. Establish the purpose, gather the right evidence and test the assumptions while there is still time to act on what the value is telling you.